A detailed history of Narus Financial Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Narus Financial Partners, LLC holds 2,050 shares of NVO stock, worth $291,858. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,050
Previous 2,000 2.5%
Holding current value
$291,858
Previous $207 Million 27.22%
% of portfolio
0.11%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$102.11 - $135.92 $5,105 - $6,795
50 Added 2.5%
2,050 $263 Million
Q4 2023

Jan 25, 2024

BUY
$87.78 - $105.45 $175,560 - $210,900
2,000 New
2,000 $207 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Narus Financial Partners, LLC Portfolio

Follow Narus Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Narus Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Narus Financial Partners, LLC with notifications on news.